home All News open_in_new Full Article
European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy
BAAR, Switzerland — Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® (defatted powder of Arachis hypogaea L., semen (peanut)) for the treatment of toddlers (ages 1 through 3) with a confirmed diagnosis of peanut allergy. The marketing authorisation covers […]
today 19 hours ago attach_file Economics
attach_file
Other
attach_file
Politics
attach_file
Economics
attach_file
Sport
attach_file
Events
attach_file
Culture
attach_file
Other
attach_file
Politics
attach_file
Economics
attach_file
Sport
attach_file
Events
attach_file
Other
attach_file
Politics
attach_file
Economics
attach_file
Events
attach_file
Politics
attach_file
Events
ID: 15487154